DIFFERENCES AMONG HUMAN TUMOR-CELL LINES IN THE EXPRESSION OF GLUTATHIONE TRANSFERASES AND OTHER GLUTATHIONE-LINKED ENZYMES

被引:81
作者
CASTRO, VM
SODERSTROM, M
CARLBERG, I
WIDERSTEN, M
PLATZ, A
MANNERVIK, B
机构
[1] UNIV UPPSALA,CTR BIOMED,DEPT BIOCHEM,BOX 576,S-75123 UPPSALA,SWEDEN
[2] UNIV STOCKHOLM,ARRHENIUS LAB,S-10691 STOCKHOLM,SWEDEN
关键词
D O I
10.1093/carcin/11.9.1569
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A large number of human tumor cell lines of various origins have been investigated with respect to expression of glutsthione-linked enzymes in the cytosol fraction. The amounts of the different enzymes were estimated by use of activity measurements and by silver staining or immunoblot analysis after electrophoresis of cytosol fractions purified by affinity chromatography on S-hexylglutathione Sepharose. Class Pi glutathione transferase was the most abundant enzyme in most tumor cells; the cell lines HepG2 and Raji were exceptions in not expressing significant amounts of this enzyme. HepG2 cells derive from hepatocytes, which normally do not express the class Pi enzyme, whereas Raji cells originate from B-lymphocytes, which normally do express a class Pi glutathione transferase. The highest level of the class Pi transferase, in terms of protein reacting with antibodies as well as enzyme activity, was noted in the colon carcinoma cell line LS174T. Hu549Pat cells, EBV-trans formed B-lymphocytes, also expressed high levels of a protein reacting with antibodies specific for class Pi glutathione transferases, but did not display any significant activity with ethacrynic acid, a substrate characteristic for this class. Class Alpha and class Mu glut.athlone transferases, in cell lines expressing these isoenzymes, were present in significantly lower concentrations than the class Pi enzyme. Most of the tumor cells contained a class Alpha transferase composed of 27.5 kd subunits, which has the physicochemical and immunological properties of the most basic glutathione transferase found in human skin. In several cell lines, a protein was detected with an apparent subunit Mr valueof 30 kd that was tentatively identified as an additional class Alpha glutathione transferase not previously described. Inaddition, other glutathione-linked enzyme activities, namely glutathione peroxidase, glutathione reductase and glyoxalase I, were assayed with specific substrates in the cytosolic fraction of the tumor cells; glyoxalase I could also be estimated semiquantilatively by silver staining of SDS)-PAGIE cells after affinity chromatography. Like the glutathione transferases, these enzymes displayed distinctly different levels of expres sion in the various cell lines. Thus, virtually every cell line was found to have a unique pattern of glutathione-linked enzymes, suggesting that the resistance phenotypes of thecells differ accordingly. © 1990 Oxford University Press.
引用
收藏
页码:1569 / 1576
页数:8
相关论文
共 76 条
  • [1] CONTROLLED SYNTHESIS OF HBSAG IN A DIFFERENTIATED HUMAN-LIVER CARCINOMA-DERIVED CELL-LINE
    ADEN, DP
    FOGEL, A
    PLOTKIN, S
    DAMJANOV, I
    KNOWLES, BB
    [J]. NATURE, 1979, 282 (5739) : 615 - 616
  • [2] EPSTEIN-BARR VIRUS SUSCEPTIBILITY OF NORMAL HUMAN B-LYMPHOCYTE POPULATIONS
    AMAN, P
    EHLINHENRIKSSON, B
    KLEIN, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (01) : 208 - 220
  • [3] INDUCTION OF ERYTHROID-DIFFERENTIATION IN THE HUMAN LEUKEMIA CELL-LINE K562
    ANDERSSON, LC
    JOKINEN, M
    GAHMBERG, CG
    [J]. NATURE, 1979, 278 (5702) : 364 - 365
  • [4] ARRICK BA, 1984, CANCER RES, V44, P4224
  • [5] PROTECTIVE ROLE OF THE GLUTATHIONE REDOX CYCLE AGAINST ADRIAMYCIN-MEDIATED TOXICITY IN ISOLATED HEPATOCYTES
    BABSON, JR
    ABELL, NS
    REED, DJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1981, 30 (16) : 2299 - 2304
  • [6] BALDWIN HT, 1976, IN VITRO ROCKVILLE, V12, P180
  • [7] BATIST G, 1986, J BIOL CHEM, V261, P5544
  • [8] ROLE OF GLUTATHIONE AND ITS ASSOCIATED ENZYMES IN MULTIDRUG-RESISTANT HUMAN MYELOMA CELLS
    BELLAMY, WT
    DALTON, WS
    MELTZER, P
    DORR, RT
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (05) : 787 - 793
  • [9] BERHANE K, 1990, MOL PHARMACOL, V37, P251
  • [10] BERZINS K, 1983, CLIN EXP IMMUNOL, V54, P313